SOPs for Injectables V 2.0

This Standard Operating Procedure (SOP) describes the procedure for effective and validated use of Clean-In-Place (CIP) systems for cleaning lyophilizers used in sterile injectable manufacturing. The purpose is to ensure removal of product residues, microbial load, and contaminants in accordance with GMP, WHO, and ICH guidelines.
Click to read the full article.

This SOP describes the process for verifying that no cleaning residues remain on sterile injectable manufacturing equipment post-cleaning. The procedure ensures equipment surfaces are free from contaminants, chemicals, and residues before reuse, in compliance with cGMP and regulatory standards.
Click to read the full article.

This SOP provides guidelines for the routine maintenance and cleaning of packing machines used for packaging sterile injectable products. It ensures cleanliness, efficient performance, prevention of contamination, and compliance with GMP standards.
Click to read the full article.

This SOP describes the method for routine sanitization of portable water systems used in the sterile injectable manufacturing plant. It ensures that the system remains microbiologically controlled and free from contaminants that may impact product quality.
Click to read the full article.

This SOP defines the method for determining osmolality of sterile injectable products using an osmometer. Osmolality testing ensures that injectable solutions are isotonic or appropriately adjusted for patient safety and comfort, particularly for intravenous, intramuscular, or ophthalmic preparations.
Click to read the full article.

This SOP outlines the standard procedures for profiling impurities in sterile injectable pharmaceutical products. It includes identification, quantification, classification, and reporting of impurities using validated analytical methods to ensure safety, efficacy, and compliance with pharmacopeial and ICH guidelines.
Click to read the full article.

This SOP defines the standardized procedure for performing spectroscopic analysis—specifically UV-Vis, FTIR, and Near Infrared (NIR) spectroscopy—on sterile injectable solutions to evaluate their identity, concentration, and purity according to GMP and ICH guidelines.
Click to read the full article.

This SOP defines the procedures and requirements for validating analytical testing methods used to evaluate sterile injectable products. It ensures reliability, consistency, and compliance with international standards such as ICH Q2(R1).
Click to read the full article.

This Standard Operating Procedure (SOP) outlines the standardized process for performing functional testing of prefilled syringes used in sterile injectable manufacturing. Functional testing ensures that the syringe performs as intended without any mechanical failure during its intended use. The testing verifies usability, plunger movement, syringe leakage, needle attachment, and injection force.
Click to read the full article.

This Standard Operating Procedure (SOP) outlines the proper process for conducting repeat testing in the Quality Control (QC) laboratories for sterile injectable products. The procedure ensures that any repeat analysis is scientifically justified, documented, reviewed, and approved in accordance with current Good Manufacturing Practices (cGMP) and data integrity principles.
Click to read the full article.